Corpus Intelligence IC Memo — METHODIST MIDLOTHIAN MEDICAL CENTER 2026-04-26 18:42 UTC
IC Memo — METHODIST MIDLOTHIAN MEDICAL CENTER
Investment Committee Memorandum | TX | 46 beds | Grade C | EBITDA uplift $5.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

METHODIST MIDLOTHIAN MEDICAL CENTER

CCN 670300 | ELLIS, TX | 46 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

METHODIST MIDLOTHIAN MEDICAL CENTER is a 46-bed suburban community hospital in ELLIS, TX with $69.3M in net patient revenue and a 2.7% operating margin. The hospital serves a payer mix of 22.0% Medicare, 1.0% Medicaid, and 77.0% commercial.

Thesis: Turnaround. Our ML models identify $5.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 2.7% to 10.1% (+736bps).

Net Revenue HCRIS$69.3M
Current EBITDA COMPUTED$1.9M
Operating Margin COMPUTED2.7%
Occupancy HCRIS39.7%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS25.1%
Distress Probability ML48.3%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
283
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 2.7% places it above the state median. Among 283 size-comparable peers (23-92 beds), the median margin is -2.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (23-92), prioritizing same-state peers. 283 hospitals in the comp set.

HospitalStateBedsRevenueMargin
METHODIST MIDLOTHIAN MEDICAL C (Target)TX46$69.3M2.7%
DECATUR COMMUNITY HOSPITALTX81$361.0M-15.5%
WISE HEALTH SYSTEM - PARKWAYTX36$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%
CORYELL MEMORIAL HOSPITALTX25$305.9M-1.5%
BAYLOR HEART AND VASCULAR HOSPTX53$255.0M30.0%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%
LAKE GRANBURY MEDICAL CENTERTX53$181.6M38.5%
METHODIST HOSPITAL FOR SURGERYTX32$178.4M22.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.5M+210bp18mo
Cost to Collect4.5%2.5%$1.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$843K+122bp9mo
Clean Claim Rate88.0%96.0%$44K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.5M
Cost to Collect
$1.4M
Denial Rate Reduction
$1.4M
A/R Days Reduction
$843K
Clean Claim Rate
$44K
Total EBITDA Uplift$5.1M
Current EBITDA$1.9M
+ RCM Uplift+$5.1M
Pro Forma EBITDA$7.0M
Current Margin2.7%
Pro Forma Margin10.1%
WC Released (1x)$2.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$2.9M$63.4M21.87x85.3%
Base (11x exit)10.0x11.0x$2.9M$70.7M24.38x89.4%
Bull Case9.0x11.0x$2.6M$88.5M33.90x102.3%
Bull (12x exit)9.0x12.0x$2.6M$97.3M37.28x106.2%
Bear Case11.0x10.0x$3.2M$37.0M11.59x63.2%
Bear (11x exit)11.0x11.0x$3.2M$41.7M13.08x67.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 283 hospitals with 23-92 beds
  • Same-state prioritization (n=284)
  • Comp margins: P25=-21.1% / P50=-2.5% / P75=10.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.